Related Experiment Video
Updated: Jun 16, 2026
05:34
Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
[Chronic obstructive pulmonary disease and cardiovascular diseases]
Ewa Passowicz-Muszyńska1, Anna Gostkowska-Malec, Renata Jankowska
1emuszyn@wp.pl
Pneumonologia I Alergologia Polska
|February 18, 2010
Summary
Chronic obstructive pulmonary disease (COPD) increases cardiovascular death risk, independent of smoking. Systemic inflammation in COPD may accelerate atherosclerosis, worsening outcomes.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Medicine
- Inflammation Research
Context:
- Chronic obstructive pulmonary disease (COPD) is a major global health issue.
- COPD patients face higher risks of cardiovascular diseases, osteoporosis, and lung cancer.
- Impaired lung function is linked to increased cardiovascular mortality, even without smoking.
Purpose:
- To review the intricate relationship between COPD and cardiovascular diseases, particularly atherosclerosis.
- To explore the role of systemic inflammation in both COPD and atherosclerosis.
- To present preliminary data on the potential impact of statin therapy on COPD.
Summary:
- COPD is a leading cause of death, associated with increased cardiovascular risks.
- Epidemiological data suggest lung function impairment independently predicts cardiovascular death.
- Shared risk factors, including genetics and systemic inflammation, link COPD and atherosclerosis progression.
Impact:
- Highlights the systemic nature of COPD beyond the lungs.
- Emphasizes the importance of managing cardiovascular risk in COPD patients.
- Suggests potential therapeutic targets, like statins, for improving COPD outcomes.
More Related Videos
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation